Reaction
Actinomycotic Sepsis reporting signals
As of the last recalculation, Actinomycotic Sepsis appears in 25 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is CANAKINUMAB (PRR 4,086.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Canakinumab | 17 | 4,086.0 | 4,092.5 |
| Busulfan | 18 | 3,398.9 | 3,402.9 |
| Alemtuzumab | 18 | 2,764.7 | 2,767.3 |
| Anakinra | 17 | 2,664.1 | 2,666.9 |
| Indomethacin | 14 | 1,998.0 | 2,000.1 |
| Thalidomide | 17 | 1,202.6 | 1,203.1 |